Assessment of infant dose through milk in a lactating woman taking Amisulpride and Desvenlafaxine for treatment-resistant depression

Abstract:This study presents the case of a 35-year-old breastfeeding mother who delivered her fourth child 5 months previously and was prescribed 100 mg amisulpride twice daily and 250 mg desvenlafaxine in the morning for treatment-resistant depression. Arriving at this regimen took approximately 2